Therapeutic Hotline: Effectiveness of the Association of Cetirizine and Topical Steroids in Lichen Planus Pilaris – An Open-Label Clinical Trial Article Summary by Soneet Dhillon, MS | MD Candidate | Chicago Medical School Lichen planus pilaris, also known as Lichen Planopilaris (LPP), is an inflammatory hair loss condition that can cause permanent scarring of [...]

Oral Minoxidil Improves Background Hair Thickness in Lichen Planopilaris Article summary by Song Park, MD | Board-Certified Dermatologist | University of Washington Department of Dermatology Low-dose oral minoxidil (LDOM) has been increasingly used for a variety of hair loss conditions. Recent paper reports that LDOM may improve thickness of existing hairs in lichen planopliaris [...]

Cetirizine for Hair Loss? Article Summary by Soneet Dhillon, MS | MD Candidate | Chicago Medical School What is Cetirizine? Cetirizine (Zyrtec ®) is an oral antihistamine available over the counter, which is typically used to relieve allergy symptoms such as watery eyes, runny nose, sneezing, and itching. Historically, cetirizine has only been used [...]

Advocating for ICD-10-CM Coding for Central Centrifugal Cicatricial Alopecia (CCCA) and Frontal Fibrosing Alopecia (FFA). What is an ICD-10-CM code? ICD-10 codes are alphanumeric codes used by doctors, health insurance companies, and public health agencies across the world to represent diagnoses. Every disease, disorder, injury, infection, and symptom should have its own ICD-10 code, [...]

Low Dose Oral Minoxidil in female patients with Lichen planopilaris: Real-life experience Article Summary by Wonder Edem | MD Candidate 2024 |University of California, Riverside School of MedicineLichen planopilaris (LPP) is one of the most common forms of scarring hair loss. It mainly affects women within ages from 40 to 60. For patients with LPP, the [...]

Management of Scarring Alopecia CARF MSAB member, Jerry Shariro, MD shares his presentation on the difference in scarring alopecia at the Maui Derm NP+PA Fall Conference.  Click HERE to view the presentation information as posted in Dermatology Times.